-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

What's Next for Patients with Relapsed or Refractory Multiple Myeloma after Multiple Lines of Therapy?

Sponsor: Janssen Biotech, Inc.
Program: Product Theaters
Sunday, December 11, 2022: 11:30 AM-12:30 PM
Hall J - Theater 6 (Ernest N. Morial Convention Center)
Jessica Fowler, PhD, Janssen Biotech, Inc. , Thomas S. Lin, MD, PhD, Janssen Biotech, Inc. and Saurabh N Patel, MD, Janssen Biotech, Inc.
No relevant conflicts of interest to declare.
This presentation is intended for U.S. based registered meeting attendees

For in-person participants only

See more of: Product Theaters